India's Decade of Collaboration
Harvard Business Review
MAY 31, 2011
In this fluid system, Biocon finances CMI's inventive R&D, while using the funds from the Pfizer deal to finance its own R&D and go-to-market activities. The vision and purpose of Kiran Mazumdar-Shaw , chairman and managing director of Biocon, is to deliver affordable drugs to the masses in both India and other markets.
13 
Let's personalize your content